Form 4: Cosmos Health Director Acquires Shares

Director Theodoros Karkantzos acquired 20,000 shares of Cosmos Health common stock through an incentive plan.

Summary

• Director Theodoros Karkantzos acquired 20,000 shares of common stock on May 19, 2026.
• The shares were acquired at a price of $0.283 per share.
• Following the transaction, the director's total beneficial ownership is 35,000 shares.
• The transaction was executed under the Issuer's 2024 & 2025 Omnibus Incentive Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it represents standard director compensation and alignment rather than a significant market-moving event.

Positives

• Director demonstrates alignment with shareholder interests through increased equity ownership.
• Acquisition was part of a standard incentive plan, indicating compensation-based equity accumulation.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that director equity acquisitions are generally viewed as a positive signal of internal confidence in the company's long-term prospects, particularly in the healthcare sector where equity-based compensation is standard for retention.

Comparison to Industry Standards

• The use of Omnibus Incentive Plans for director compensation is consistent with standard corporate governance practices for small-cap healthcare companies.
• The acquisition price of $0.283 reflects the current market valuation of the issuer's equity.

Stakeholder Impact

• Shareholders may view the director's increased stake as a sign of confidence in the company's direction.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

Cosmos Health, COSM, Insider Trading, Form 4, Equity Incentive Plan, Director Ownership